Endosomal and lysosomal effects of desferrioxamine: Protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest

Free Radical Biology and Medicine

Volumn 35, Issue 7, 2003, Pages 719-728

  Doulias, Paschalis Thomas ^a   Christoforidis, Savvas ^a   Brunk, Ulf T ^b   Galaris, Dimitrios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Cell cycle arrest; Desferrioxamine; DNA damage; Dynamin; Endosomes; Free radicals; Lysosomes; Rab5

Indexed keywords

DEFEROXAMINE MESYLATE; DYNAMIN; HYDROGEN PEROXIDE; IRON CHELATE; RAB PROTEIN;

ARTICLE; CELL COMPARTMENTALIZATION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PARAMETERS; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; ENDOCYTOSIS; ENDOSOME; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IRON CHELATION; LYSOSOME; METAPHASE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 0142227699     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00396-4     Document Type: Article

References (51)

1. Ames B., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
2. Griendling K.K., Harrison D.G. Dual role of reactive oxygen species in vascular growth. Circ. Res. 85:1999;562-563.
3. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
4. Forman H.J., Torres M. Redox signaling in macrophages. Mol. Aspects Med. 22:2001;189-216.
5. 2-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells. Free Radic. Biol. Med. 29:2000;736-746.
6. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:1997;351-369.
7. Burdon R. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
8. Brown M.R., Miller F.J. Jr., Li W.G., Ellingson A.N., Mozena J.D., Chatterjee P., Engelhardt J.F., Zwacha R.M., Oberley L.W., Fang X., Spector A.A., Weintraub N.L. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ. Res. 85:1999;524-533.
9. 2+-dependent DNA damage in human peripheral blood lymphocytes. Free Radic. Biol. Med. 26:1999;548-556.
10. 2 induce apoptosis through Fenton chemistry independent of the cellular thiol state . Free Radic. Biol. Med. 30:2001;1008-1018.
11. 2 . Free Radic. Biol. Med. 33:2002;691-702.
12. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic. Biol. Med. 23:1997;783-792.
13. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species its mechanism and measurement in mammalian systems . FEBS Lett. 281:1991;9-19.
14. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease. Methods Enzymol. 186:1992;1-85.
15. Galey J.B. Potential use of iron chelators against oxidative damage. Adv. Pharmacol. 38:1997;167-203.
16. Chevion M. A site-specific mechanism for free radical-induced biological damage the essential role of redox-active transition metals . Free Radic. Biol. Med. 5:1988;27-37.
17. 2 is a consequence of lysosomal rupture. Biochem. J. 356:2001;549-555.
18. Brunk U.T., Neuzil J., Eaton J.W. Lysosomal involvement in apoptosis. Redox Rep. 6:2001;91-97.
19. Li W., Yuan X., Nordgren G., Dalen H., Dobowchik G.M., Firestone R.A., Brunk U.T. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett. 470:2000;35-39.
20. Cable H., Lloyd J.B. Cellular uptake and release of two contrasting iron chelators. J. Pharm. Pharmacol. 51:1999;131-134.
21. Barbouti A., Doulias P.-T., Zhu B.-Z., Frei B., Galaris D. Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic. Biol. Med. 31:2001;490-498.
22. Öllinger K., Brunk U.T. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic. Biol. Med. 19:1995;565-574.
23. Lloyd J.B., Cable H., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem. Pharmacol. 41:1991;1361-1363.
24. Yu Z., Person H.L., Eaton J.W., Brunk U.T. Intralysosomal iron a major determinant of oxidant-induced cell death . Free Radic. Biol. Med. 34:2003;1243-1252.
25. Person H.L., Yu Z., Tirosh O., Eaton J.W., Brunk U.T. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic. Biol. Med. 34:2003;1295-1305.
26. Stenmark H., Vitale G., Ullrich O., Zerial M. Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell. 83:1995;423-432.
27. McBride H.D., Rybin V., Murphy C., Giner A., Teasdale R., Zerial M. Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between EEA1 and Syntaxin 13. Cell. 98:1999;377-386.
28. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 184:1988;461-470.
29. Collins A.R., Ma A., Duthie S.J. The kinetics of repair of oxidative DNA damage (strand breaks and oxidized pyrimidines) in human cells. Mutat. Res. 336:1995;69-77.
30. Duthie S.J., Haedon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J. 12:1998;1491-1497.
31. Chavrier P., Parton R.G., Hauri H.P., Zerial M. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell. 62:1990;317-329.
32. Stenmark H., Valencia A., Martinez O., Ullrich O., Goud B., Zerial M. Distinct structural elements of Rab5 define its functional specificity. EMBO J. 13:1994;575-583.
33. Damke H., Baba T., Warnock D.E., Schmid S.L. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell. Biol. 127:1994;915-934.
34. Henley J.R., Krueger E.W., Oswald B.J., McNiven M.A. Dynamin-mediated internalization of caveolae. J. Cell Biol. 141:1998;85-99.
35. Damke H., Baba T., van der Bliek A.M., Schmid S.L. Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin. J. Cell Biol. 131:1995;69-80.
36. Bucci C., Parton R.G., Mather I.H., Stunnenberg H., Simons K., Hoflack B., Zerial M. The small GTPase Rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 70:1992;715-728.
37. McLauchlan H., Newell J., Morrice N., Osborne A., West M., Smythe E. A novel role for Rab5-GDI in ligand sequestration into clathrin-coated pits. Curr. Biol. 8:1998;34-45.
38. Oh P., McIntosh D.P., Schnitzer J.E. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141:1998;101-114.
39. Sever S., Muhlberg A.B., Schmid S.L. Impairment of dynamin's GAP domain stimulates receptor-mediated endocytosis. Nature. 398:1999;481-486.
40. Lanzetti L., Rybin V., Malabarba M.G., Christoforidis S., Scita G., Zerial M., Di Fiore P.P. The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature. 408:2000;374-377.
41. Simonsen A., Lippe R., Christoforidis S., Gaullier J.M., Brech A., Callagham J., Toh B.H., Murphy C., Zerial M., Stenmark H. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 394:1998;494-498.
42. Cantoni O., Sestili P., Cattabeni F., Bellomo G., Pou S., Cohen M., Cerutti P. Calcium chelator Quin 2 prevents hydrogen peroxide-induced DNA breakage and cytotoxicity. Eur. J. Biochem. 182:1989;209-212.
43. Scafer F.Q., Buettner G.R. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic. Biol. Med. 28:2000;1175-1181.
44. Robinson M.S., Watts C., Zerial M. Membrane dynamics in endocytosis. Cell. 84:1996;13-21.
45. Kip1 expression . Biochem. J. 366:2002;613-621.
46. Fan L., Iyer J., Zhu S., Frick K.K., Wada R.K., Eskenazi A.E., Berg P.E., Ikegaki N., Kennett R.H., Frantz C.N. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res. 61:2001;1073-1079.
47. Jain M., Arvanitis C., Chu K., Dewey W., Leonhardt E., Trinh M., Sundberg C.D., Bishop J.M., Felsher D.W. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science. 297:2002;102-104.
48. Renton F.J., Jeitner T.M. Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators. Biochem. Pharmacol. 51:1996;1553-1561.
49. Gao J., Richardson D.R. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV the mechanisms involved in inhibiting cell-cycle progression . Blood. 98:2001;842-850.
50. Abeysinghe R.D., Greene B.T., Haynes R., Willingham M.C., Turner J., Planalp R.P., Brechbiel M.W., Torti F.M., Torti S.V. p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Carcinogenesis. 22:2001;1607-1614.
51. Le N.T.V., Richardson D.R. The role of iron in cell progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta. 1603:2002;31-46.